With the U.S. deficit swelling, Medicare spending in sharper focus and a $39.9b debt pile driving interest costs higher, investors are seeing how government budgets can ripple through markets in real time. That stress can unsettle broad indices yet create pockets of potential in Medicare exposed insurers. In this context, this article walks through 3 U.S. healthcare payer stocks tied to these trends and explains why they might matter for your watchlist.

The stocks covered below are just a starting sample, and the full screen surfaced 17 more companies with equally compelling narratives that are not included in this article. To go further, head straight into the U.S. Healthcare Payers and Managed Care (Medicare-Exposed Insurers) screener to identify, compare, and analyze the Medicare exposed insurers that best fit your own conviction.

Ardent Health (ARDT)

Overview: Ardent Health is a U.S. hospital and clinic operator based in Tennessee, running acute care and rehabilitation hospitals, outpatient centers, urgent care, telehealth and specialty clinics that cover everything from cardiology and oncology to orthopedics and women’s health.

Market Cap: $1.56b

Ardent Health sits at the intersection of growing Medicare and federal healthcare spending and real world patient demand, which is why it can matter for a portfolio as deficits and entitlement costs move to the forefront. The company is pushing harder into higher margin outpatient and ambulatory services and has leaned on AI enabled tools to reduce some labor strain. At the same time, thin 1.2% net margins and softer recent earnings highlight how challenging hospital economics can be. The company is engaged in cost saving programs and payer contract work, but heavy reliance on external borrowing and exposure to regulatory shifts around Medicaid and reimbursement keep the risk side of the story significant and worth closer inspection.

Ardent Health appears caught between thin 1.2% margins and a sizable Medicare-driven demand story, yet the real puzzle lies in the Ardent Health financial footing. Get the full picture in the Ardent Health financial health report

Build your own Medicare exposed shortlist

Ardent Health and the two other insurers in this article all surfaced from a single screener, but the real advantage comes when you shape the filters yourself. Use our flexible Screener to combine metrics such as valuation, growth, and balance sheet strength, or use our curated Investing Ideas for ready made starting points.

InnovAge Holding (INNV)

Overview: InnovAge Holding runs Program of All Inclusive Care for the Elderly centers across several U.S. states, coordinating medical, in home and transportation services so frail seniors can stay in their communities instead of moving into nursing homes. The company wraps primary care, therapies, dental, mental health and daily support into one bundle for participants who are often covered by Medicare and Medicaid.

Operations: InnovAge Holding generates virtually all of its US$949 million in revenue from its PACE segment, with only a very small contribution from other activities, and all of this is earned in the United States.

Market Cap: US$1.48b

InnovAge Holding provides direct exposure to the growing need for coordinated care for high acuity seniors, while also linking closely to how Medicare and Medicaid dollars are spent. The company is working to tighten medical costs, renegotiate high cost providers and demonstrate its expense profile to state partners. These efforts matter in an environment where federal deficits and entitlement budgets are under scrutiny. At the same time, the company remains unprofitable, carries losses from new centers and faces regulatory and compliance costs that can pressure margins if not contained. Analysts have discussed the potential for a shift to profitability and new leadership has emphasized value based care execution. The key consideration for investors is whether the current pricing appropriately reflects both the potential benefits and these execution risks.

InnovAge Holding may appear to be a stalled story on the surface, yet its push toward tighter care coordination could be setting up a sharp turn. Get the context in the analysis report for InnovAge Holding

Tactile Systems Technology (TCMD)

Overview: Tactile Systems Technology is a U.S. medtech company that makes at home pneumatic compression devices and related tools to treat chronic conditions such as lymphedema, chronic edema, venous disease and respiratory disorders. Its portfolio ranges from Flexitouch and Entre compression systems to the Nimbl platform, the AffloVest airway clearance vest and the Kylee app that helps patients monitor symptoms and share data with clinicians.

Market Cap: $657 million

Tactile Systems Technology provides targeted exposure to Medicare reimbursed chronic care at a time when federal healthcare spending on seniors is a growing share of the budget. The company is broadening beyond Flexitouch into products such as AffloVest and Nimbl. It recently launched a next generation AffloVest system and entered into an exclusive MyoSleeve distribution deal for VA and DoD patients, which together expand its respiratory and vascular presence. Earnings quality is described as high and margins are improving, while revenue growth trails the wider market and returns on equity are in the low double digits. Heavy reliance on reimbursement decisions and external funding adds risk, so an important consideration is whether the product pipeline and share repurchases are sufficient to balance those pressures.

Tactile Systems Technology looks like a simple Medicare chronic care story, yet its expanding product mix hints at something bigger. See how the analyst forecasts for Tactile Systems Technology frames where this strength could go next.

Seeking Fresh Alternatives Before Others Do

Markets move fast and the most interesting stories rarely stay quiet for long. Catch potential breakout momentum and fresh under the radar ideas before the crowd does. Act now.

• Spot companies quietly building strength while others are distracted by headlines by scanning the list of solid balance sheet and fundamentals (50 results) and focusing on balance sheets that can handle tougher conditions.
• Explore the next leg of the AI hardware and data trend by using the 57 AI infrastructure stocks to look at enablers powering everything from chips to power and cooling.
• Review potential supply pinch points by checking the 28 best rare earth metal stocks and examining miners and processors involved in EVs, wind turbines and advanced electronics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.